Method and apparatus for safe and efficient delivery of cardiac stress augmentation pacing
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/365
A61N-001/362
A61N-001/37
출원번호
US-0770351
(2010-04-29)
등록번호
US-8958873
(2015-02-17)
발명자
/ 주소
Arcot-Krishnamurthy, Shantha
Shuros, Allan C.
Stolen, Craig
Shipley, Robert
출원인 / 주소
Cardiac Pacemakers, Inc.
대리인 / 주소
Schwegman Lundberg & Woessner, P.A.
인용정보
피인용 횟수 :
2인용 특허 :
95
초록▼
A cardiac pacing system controls the progression of a cardiac disorder such as heart failure by delivering cardiac stress augmentation pacing to create or augment regional stress in the heart according to a delivery schedule programmed for a patient. Various events associated with the patient's cond
A cardiac pacing system controls the progression of a cardiac disorder such as heart failure by delivering cardiac stress augmentation pacing to create or augment regional stress in the heart according to a delivery schedule programmed for a patient. Various events associated with the patient's conditions, activities, and other treatments may render the cardiac stress augmentation pacing risky or ineffective. The system detects such events before and during each cardiac stress augmentation pacing session and modifies the delivery schedule in response to the detection of each event to ensure patient safety and therapy efficiency.
대표청구항▼
1. A cardiac pacing system, comprising: a pacing output circuit adapted to deliver pacing pulses; anda pacing control circuit coupled to the pacing output circuit and adapted to control the delivery of the pacing pulses, the pacing control circuit including: a memory circuit storing a delivery sched
1. A cardiac pacing system, comprising: a pacing output circuit adapted to deliver pacing pulses; anda pacing control circuit coupled to the pacing output circuit and adapted to control the delivery of the pacing pulses, the pacing control circuit including: a memory circuit storing a delivery schedule specifying timing for initiating stress augmentation pacing sessions each including a session duration during which the pacing pulses are delivered using pacing parameters selected to augment myocardial mechanical stress to a level effecting cardioprotection against myocardial injury or deterioration by increasing a degree of ventricular asynchrony; wherein the delivery schedule is programmed to specify the stress augmentation pacing sessions to be delivered on a periodic basis at a session frequency between approximately 1 and 12 sessions each day and each including alternating non-pacing and pacing periods, the non-pacing periods each having a non-pacing duration during which no pacing pulse is timed to be delivered, the pacing periods each having a specified pacing duration during which a plurality of the pacing pulses is timed to be delivered using pacing parameters selected to augment myocardial mechanical stress to the level effecting cardioprotection against myocardial injury or deterioration; an inhibitory signal input to receive an inhibitory signal indicative of detection of an event potentially reducing effectiveness of stress augmentation pacing during each of the stress augmentation pacing sessions; anda stress augmentation pacing controller coupled to the memory circuit and the inhibitory signal input, the stress augmentation pacing controller programmed to initiate each of the stress augmentation pacing sessions according to the delivery schedule if the inhibitory signal is not present at a scheduled beginning of the each of the stress augmentation pacing sessions and modify the delivery schedule by rescheduling one or more of the stress augmentation pacing sessions if the inhibitory signal is present at the scheduled beginning of the each of the stress augmentation pacing sessions. 2. The system of claim 1, comprising: one or more physiological sensors adapted to sense one or more physiological signals; andan inhibitory event detector adapted to detect inhibitory events from at least a first physiological signal of the sensed one or more physiological signals and produce the inhibitory signal in response to a detection of at least one of the inhibitory events. 3. The system of claim 2, comprising a user input receiver adapted to receive one or more user signals, and wherein the inhibitory event detector is adapted to detect inhibitory events from at least the first physiological signal and a first user signal of the user signals. 4. The system of claim 3, wherein the pacing control circuit comprises a terminating signal input to receive a terminating signal, and the stress augmentation pacing controller is programmed to terminate each of the cardiac stress augmentation pacing sessions in response to the terminating signal received during the each of the stress augmentation pacing sessions. 5. The system of claim 4, comprising a terminating event detector adapted to detect terminating events using at least one of a second physiological signal of the sensed one or more physiological signals and a second user signal of the user signals and adapted to produce the terminating signal in response to a detection of at least one of the terminating events. 6. The system of claim 5, wherein the one or more physiological sensors comprise a temperature sensor adapted to sense a body temperature, and the inhibitory event detector is adapted to produce the inhibitory signal when the sensed body temperature exceeds a specified threshold temperature. 7. The system of claim 5, wherein the one or more physiological sensors comprise a glucose sensor adapted to sense a glucose signal indicative of a blood glucose level, and the inhibitory event detector is adapted to produce the inhibitory signal when the blood glucose level exceeds a specified threshold level. 8. The system of claim 5, wherein the one or more physiological sensors comprise a cardiac sensing circuit adapted to sense one or more cardiac signals, and the terminating event detector is adapted to produce the terminating signal in response to an amplitude of an ST segment of at least one cardiac signal of the one or more cardiac signals exceeding a specified threshold amplitude. 9. The system of claim 5, wherein the one or more physiological sensors comprise a respiratory sensor adapted to sense one or more respiratory signals indicative of one or more respiratory parameter, and the terminating event detector is adapted to produce the terminating signal in response to a substantial change in the respiratory pattern as indicated by a substantial change in one or more values of the one or more respiratory parameters. 10. The system of claim 5, wherein the user input receiver is adapted to receive a drug signal indicative of an administration of a specified drug, the inhibitory event detector is adapted to produce the inhibitory signal in response to receipt of the drug signal, and the terminating event detector is adapted to produce the terminating signal in response to the drug signal. 11. The system of claim 5, wherein the user input receiver is adapted to receive a food signal indicative of a substantial food consumption, the inhibitory event detector is adapted to produce the inhibitory signal in response to the food signal, and the terminating event detector is adapted to produce the terminating signal in response to receipt of the food signal. 12. A method for operating a cardiac pacing system, comprising: determining whether an inhibitory signal is present before initiating each of stress augmentation pacing sessions according to a delivery schedule using an implantable medical device, the inhibitory signal indicative of detection of an event potentially reducing effectiveness of stress augmentation pacing during the each of stress augmentation pacing sessions, the stress augmentation pacing sessions each including a session duration during which pacing pulses are delivered from the implantable medical device using pacing parameters selected to augment myocardial mechanical stress to a level effecting cardioprotection against myocardial injury or deterioration by increasing a degree of ventricular asynchrony, the delivery schedule stored in the implantable medical device and specifying timing for initiating the stress augmentation pacing sessions; timing the stress augmentation pacing sessions to be delivered on a periodic basis at a session frequency between approximately 1 and 12 sessions each day; and timing the delivery of the pacing pulses during the each of the stress augmentation pacing sessions, including timing alternating non-pacing and pacing periods, the non-pacing periods each having a non-pacing duration during which no pacing pulse is timed to be delivered, the pacing periods each having a specified pacing duration during which a plurality of the pacing pulses is timed to be delivered using pacing parameters selected to augment rnyocardial mechanical stress to the level effecting cardioprotection against myocardial injury or deterioration; initiatingthe each of the stress augmentation pacing sessions according to the delivery schedule using the implantable medical device if the inhibitory signal is not present; andmodifying the delivery schedule by rescheduling one or more of the stress augmentation pacing sessions using the implantable medical device if the inhibitory signal is present. 13. The method of claim 12, comprising: sensing one or more physiological signals;detecting inhibitory events using at least a first physiological signal of the sensed one or more physiological signals; andproducing the inhibitory signal m response to a detection of at least one of the inhibitory events. 14. The method of claim 13, comprising: receiving user signals from a user; anddetecting the inhibitory events using at least the first physiological signal and a first user signal of the user signals. 15. The method of claim 14, comprising: detecting terminating events using at least one of a second physiological signal of the sensed one or more physiological signals and a second user signal of the user signals; andterminating the each of the cardiac stress augmentation pacing sessions in response to a detection of at least one of the terminating events during the each of the stress augmentation pacing sessions. 16. The method of claim 15, wherein sensing the one or more physiological signals comprises sensing a body temperature, and producing the inhibitory signal comprises producing the inhibitory signal when the body temperature exceeds a specified threshold temperature. 17. The method of claim 15, wherein sensing the one or more physiological signals comprises sensing a glucose signal indicative of a blood glucose level, and producing the inhibitor signal comprises producing the inhibitory signal when the blood glucose level exceeds a specified threshold level. 18. The method of claim 15, wherein sensing the one or more physiological signals comprises sensing one or more cardiac signals, and producing the terminating signal comprises producing the terminating signal in response to an amplitude of an ST segment of at least one cardiac signal of the one or more cardiac signals exceeding a specified threshold amplitude. 19. The method of claim 15, wherein sensing the one or more physiological signals comprises sensing one or more respiratory signals indicative of one or more respiratory parameter, and producing the terminating signal comprises producing the terminating signal in response to a substantial change in the respiratory pattern as indicated by a substantial change in one or more values of the one or more respiratory parameters. 20. The method of claim 15, wherein receiving the user signals comprises receiving a drug signal indicative of an administration of a specified drug, producing the inhibitory signal comprises producing the inhibitory signal in response to receipt of the drug signal, and producing the terminating signal comprises producing the terminating signal in response to receipt of the drug signal. 21. The method of claim 15, wherein receiving the user signals comprises receiving a food signal indicative of a substantial food consumption, producing the inhibitory signal comprises producing the inhibitory signal in response to receipt of the drug signal, and producing the terminating signal comprises producing the terminating signal in response to receipt of the food signal.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (95)
Alt Eckhard (Ottobrunn DEX) Stotts Lawrence J. (Lake Jackson TX) Schmidt Matthias (Munich DEX), Accelerometer-based rate-adaptive cardiac pacing with second generation signal processing.
Suzuki Arata (Ramsey NJ) Suzuki Marcia (Ramsey NJ) Tyberg William T. (Springvalley NY) Banks George (Emerson NJ), Ambulatory physiological evaluation system including cardiac monitoring.
Suzuki Arata (Ramsey NJ) Tyberg William T. (Springvalley NY) Banks George (Emerson NJ) Suzuki Marcia (Ramsey NJ), Ambulatory physiological evaluation system including cardiac monitoring.
Koning Gerrit (Vries FL NLX) Schroeppel Edward A. (Miamar FL), Apparatus and method for adjusting heart/pacer rate relative to ejection time to obtain a required cardiac output.
Nappholz Tibor A. (Englewood CO) Dawson Albert K. (Denver CO) Lu Richard M. T. (Aurora CO) Steinhaus Bruce M. (Parker CO), Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control.
Kramer, Andrew P.; Salo, Rodney W.; Spinelli, Julio C.; KenKnight, Bruce H., Apparatus and method for reversal of myocardial remodeling with electrical stimulation.
King Gary W., Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control.
Gust H. Bardy, Automated collection and analysis patient care system and method for diagnosing and monitoring myocardial ischemia and outcomes thereof.
Kieval,Robert S.; Persson,Bruce J.; Serdar,David J.; Keith,Peter T.; Irwin,Eric D., Electrode designs and methods of use for cardiovascular reflex control devices.
Obel Israel W. P. (Johannesburg ZAX) Bourgeois Ivan (Verviers BEX), Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload.
Fischell Robert E. ; Fischell David R. ; Fischell Tim A., Implantable electronic system with acute myocardial infarction detection and patient warning capabilities.
Pastore,Joseph M.; Spinelli,Julio C.; Prinzen,Frits W.; Cornelussen,Richard N.; Vanagt,Ward Y. R., Intermittent stress augmentation pacing for cardioprotective effect.
Scheiner, Avram; Heil, Jr., Ronald W.; Kelley, Peter T.; Tockman, Bruce; Westlund, Randy; Warren, Jay A., Leads for pacing and/or sensing the heart from within the coronary veins.
Brockway, Marina; Pastore, Joseph M.; Zhang, Yi; Ricci, Carlos; Shuros, Allan; Salo, Rodney W., Method and apparatus for delivering chronic and post-ischemia cardiac therapies.
KenKnight,Bruce H.; Lovett,Eric G.; Sweeney,Robert J.; Mazar,Scott T.; Manicka,Yatheendhar, Method and apparatus for establishing context among events and optimizing implanted medical device performance.
Stadler Robert ; Nelson Shannon ; Stylos Lee ; Sheldon Todd J., Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals.
Krig,David B.; Hartley,Jesse W.; Stahl,Wyatt; Stahmann,Jeffrey E., Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia.
Ujhelyi, Michael R.; Euler, David E.; Casavant, David A.; Sheth, Nirav V., Method and arrangement for using atrial pacing to prevent early recurrence of atrial fibrillation.
Naritoku Dean K. ; Jensen Robert A. ; Browning Ronald A. ; Clark Kevin B. ; Smith Douglas C. ; Terry ; Jr. Reese S., Methods of treating traumatic brain injury by vagus nerve stimulation.
Cho,Yong K.; Erickson,Mark K.; Markowitz,H. Toby, System and method for automatically monitoring and delivering therapy for sleep-related disordered breathing.
Kramer Andrew P. ; Stahmann Jeffrey E. ; Wentkowski Rene H. ; Baker Kenneth L. ; Hartley Jesse W. ; Krig David B., System providing ventricular pacing and biventricular coordination.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.